Balaji Amines' new capacity expansion to aid FY22 revenue growth at 14-15%

"For the current year, we expect to standalone revenues to be Rs 1,500 crore and Rs 800 on a consolidated basis," he said. "Looking at a growth of 14-15 percent in revenues by FY22", he added In FY21, the company's reported revenue was at Rs 1,311 crore.

Going forward the new projects like Dimethyl Carbonate (DMC) is on track, which will be commissioned by the end of the current financial years, said Reddy, adding that they have taken a new decision of increasing capacity of Acetonitrile from 9 tonnes per day to 15 tonnes per day in couple of months.

A new plant is also being built through greenfield expansion to add new capacity of 50 tonnes per day, which will likely be commissioned by next financial year, according to the management.

Reddy said, both methylamine and ethylamine are their main products along with some derivative and specialties. "EBITDA margins were around 20-22 percent but with new capacity additions and upcoming capacities, margins of 24-25 percent should be sustainable for the full year," he said.